Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

279 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The real-world outcomes of vedolizumab in patients with ulcerative colitis in Korea: a multicenter retrospective study.
Ye BD, Cheon JH, Song KH, Kim JS, Kim YH, Yoon H, Lee KM, Kang SB, Jang BI, Park JJ, Kim TO, Lee DW, Foo CY, Shin JE, Park DI. Ye BD, et al. Among authors: kim yh, kim js, kim to. Therap Adv Gastroenterol. 2021 Jul 5;14:17562848211024769. doi: 10.1177/17562848211024769. eCollection 2021. Therap Adv Gastroenterol. 2021. PMID: 34285716 Free PMC article.
Efficacy, safety, and predictors of response to infliximab therapy for ulcerative colitis: a Korean multicenter retrospective study.
Lee KM, Jeen YT, Cho JY, Lee CK, Koo JS, Park DI, Im JP, Park SJ, Kim YS, Kim TO, Lee SH, Jang BI, Kim JW, Park YS, Kim ES, Choi CH, Kim HJ; IBD study Group of Korean Association for the Study of Intestinal Diseases. Lee KM, et al. Among authors: kim hj, kim ys, kim to, kim jw, kim es. J Gastroenterol Hepatol. 2013 Dec;28(12):1829-33. doi: 10.1111/jgh.12324. J Gastroenterol Hepatol. 2013. PMID: 23829336
A comparative study of DA-9601 and misoprostol for prevention of NSAID-associated gastroduodenal injury in patients undergoing chronic NSAID treatment.
Lee OY, Kang DH, Lee DH, Chung IK, Jang JY, Kim JI, Cho JW, Rew JS, Lee KM, Kim KO, Choi MG, Lee SW, Lee ST, Kim TO, Shin YW, Seol SY. Lee OY, et al. Among authors: kim ji, kim ko, kim to. Arch Pharm Res. 2014 Oct;37(10):1308-16. doi: 10.1007/s12272-014-0408-3. Epub 2014 May 30. Arch Pharm Res. 2014. PMID: 24871787 Free PMC article. Clinical Trial.
The effect of infliximab on patients with ulcerative colitis in Korea.
Seo HI, Park DI, Kim TO, Kim YS, Lee SH, Kim JW, Kim JH, Shin JE. Seo HI, et al. Among authors: kim ys, kim to, kim jw, kim jh. Intest Res. 2014 Jul;12(3):214-20. doi: 10.5217/ir.2014.12.3.214. Epub 2014 Jul 25. Intest Res. 2014. PMID: 25349595 Free PMC article.
Significant risk and associated factors of active tuberculosis infection in Korean patients with inflammatory bowel disease using anti-TNF agents.
Kim ES, Song GA, Cho KB, Park KS, Kim KO, Jang BI, Kim EY, Jeon SW, Lee HS, Yang CH, Lee YK, Lee DW, Kim SK, Kim TO, Lee J, Kim HW, Jee SR, Park SJ, Kim HJ. Kim ES, et al. Among authors: kim hw, kim hj, kim ko, kim ey, kim sk, kim to. World J Gastroenterol. 2015 Mar 21;21(11):3308-16. doi: 10.3748/wjg.v21.i11.3308. World J Gastroenterol. 2015. PMID: 25805938 Free PMC article.
Factors Contributing to the Preference of Korean Patients with Crohn's Disease When Selecting an Anti-Tumor Necrosis Factor Agent (CHOICE Study).
Kim ES, Kim KO, Jang BI, Lee CK, Kim HJ, Lee KM, Kim YS, Eun CS, Jung SA, Yang SK, Lee J, Kim TO, Jung Y, Seo GS, Yoon SM; IBD Study Group of the Korean Association for the Study of the Intestinal Diseases (KASID). Kim ES, et al. Among authors: kim hj, kim ko, kim ys, kim to. Gut Liver. 2016 May 23;10(3):391-8. doi: 10.5009/gnl15126. Gut Liver. 2016. PMID: 26347512 Free PMC article.
Efficacy and Safety of Infliximab Therapy and Predictors of Response in Korean Patients with Crohn's Disease: A Nationwide, Multicenter Study.
Choi CH, Song ID, Kim YH, Koo JS, Kim YS, Kim JS, Kim N, Kim ES, Kim JH, Kim JW, Kim TO, Kim HS, Kim HJ, Park YS, Park DI, Park SJ, Song HJ, Shin SJ, Yang SK, Ye BD, Lee KM, Lee BI, Lee SY, Lee CK, Im JP, Jang BI, Jeon TJ, Cho YK, Chang SK, Jeon SR, Jung SA, Jeen YT, Cha JM, Han DS, Kim WH; IBD Study Group of the Korean Association for the Study of the Intestinal Diseases. Choi CH, et al. Among authors: kim yh, kim wh, kim hj, kim n, kim js, kim ys, kim to, kim hs, kim jw, kim es, kim jh. Yonsei Med J. 2016 Nov;57(6):1376-85. doi: 10.3349/ymj.2016.57.6.1376. Yonsei Med J. 2016. PMID: 27593865 Free PMC article.
Impact of inflammatory bowel disease on daily life: an online survey by the Korean Association for the Study of Intestinal Diseases.
Kim YS, Jung SA, Lee KM, Park SJ, Kim TO, Choi CH, Kim HG, Moon W, Moon CM, Song HK, Na SY, Yang SK; Korean Association for the Study of Intestinal Diseases (KASID). Kim YS, et al. Among authors: kim hg, kim to. Intest Res. 2017 Jul;15(3):338-344. doi: 10.5217/ir.2017.15.3.338. Epub 2017 Jun 12. Intest Res. 2017. PMID: 28670230 Free PMC article.
279 results